17.Food-producing animals: proof of purchase of veterinary medicinal products
18.Food-producing animals: records of administration by a veterinary surgeon
19.Food-producing animals: records of acquisition and administration
22.Records by a holder of a wholesale dealer’s authorisation
23.Records of the receipt or supply of prescription products
24.Records of products administered to a food-producing animal under the cascade
24A.Reporting of sales and usage data in relation to antibiotics
PART 5 Miscellaneous provisions, enforcement and offences
Marketing authorisations in Great Britain in Northern Ireland
PART 4 Variations of marketing authorisations on the application of the holder
56.Duties of marketing authorisation holder in relation to pharmacovigilance
56A.Duties of marketing authorisation holder in relation to signal management process
57.Adverse events following administration of a veterinary medicinal product
58.Adverse reactions to a veterinary medicinal product administered in another country
60.Release of information by the marketing authorisation holder
60B.Powers of Secretary of State in relation to signal management process
Qualifying Northern Ireland good (QNIG) certificates
1.In this Schedule— “QNIG certificate” means a certificate issued under...
2.This Schedule applies to a veterinary medicinal product which is—...
6.The QNIG certificate holder must provide to the Secretary of...
7.Without prejudice to any other power to suspend a marketing...
8.The Secretary of State must publish any notice given under...
The manufacture of veterinary medicinal products
Classification and supply, wholesale dealers and sheep dip
PART 1 Classification and supply of authorised veterinary medicinal products
Administration of a veterinary medicinal product outside the terms of a marketing authorisation
Medicated feedingstuffs and specified feed additives
7.Authorisation of manufacturers and distributors of feedingstuffs containing medicinal premixes
8.Incorporation of a medicinal premix into an intermediate feedingstuff
11.Additional record keeping requirements relating to medicinal premixes
12.Labelling an intermediate feedingstuff containing a medicinal premix
13.Labelling of feedingstuffs containing a specified feed additive
16.Supply of intermediate feedingstuff or specified feed additive
19.Medicated feedingstuff prescriptions for feedingstuffs containing a medicinal premix
26.Possession, placing on the market and use of feedingstuffs
29.Import for incorporation into intermediate feedingstuffs or feedingstuffs for export
PART 2 Fees relating to marketing authorisations
7.Application for a marketing authorisation for a pharmaceutical , immunological or biological that is not immunological veterinary medicinal product
7A.Application for a marketing authorisation for specific applications
8.Decentralised pharmaceutical application where the United Kingdom is the reference member State
9.Application for a marketing authorisation for an immunological or biosimilar product
10.Decentralised immunological application where the United Kingdom is the reference member State
11.Application for a marketing authorisation based on informed consent
12.Application for an exceptional marketing authorisation (pharmaceutical)
13.Fees for an application for an exceptional marketing authorisation (immunological or biological non-immunological)
14.Fee for the conversion from an exceptional to a full marketing authorisation
15.Application for a marketing authorisation relating to a parallel import
16.Application to change the distribution category of a product authorised through the centralised procedure
17.Application for a variation to a marketing authorisation ....
18.Application for a variation to a marketing authorisation dealt with under worksharing procedures
19.Application for an extension dealt with under the decentralised procedure where the United Kingdom is the reference member State
20.Provision of information relating to the recognition of a United Kingdom marketing authorisation or an extension
22.Application for a reassessment of an exceptional marketing authorisation
23.Application for the renewal of a marketing authorisation obtained through mutual recognition or the decentralised procedure
PART 3 Fees payable by manufacturers
29.Application for a variation of a manufacturing authorisation
30.Inspection of sites authorised to manufacture a product for administration under the cascade
30B.Assessment of a variation of an authorisation to manufacture an autogenous vaccine
33.Inspection of a site where immunological veterinary medicinal products are manufactured
34.Inspection of a site where sterile veterinary medicinal products are manufactured
35.Inspection of a site where no immunological or sterile veterinary medicinal products are manufactured
36.Inspection of a site where veterinary medicinal products are assembled
38.Animal blood bank or non-food animal stem cell centre authorisations